Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Therapeutic Cancer Vaccines: Evolving Strategies and Pipeline Prospects' returned 5 results - Page 1 of 1  FEATURED RESULTS Cancer Diagnostic Testing World Markets Drug Delivery in Cancer - Technologies, Markets and Companies Antibody Drug Target Atlas in Oncology Molecular Diagnostics in Cancer Testing Drug Delivery in Cancer - Technologies, Markets and Companies   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Advances in Vaccine Technology and Delivery   Espicom Business Intelligence Ltd, Jan 2010, Pages: 164 to the prophylactic vaccine pipeline, the pipeline of therapeutic cancer vaccines has a higher proportion of vaccines in late-stage trials. These late-stage products utilise technologies that have not been proven Antiviral Therapeutics - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 481 This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer   Decision Resources, Inc., March 2009, Pages: 49 types of therapeutic cancer MAb deals have taken place in the last two years? What strategies are companies using? - The emerging cancer vaccine market is significantly behind the therapeutic cancer MAb Biotechnology in India - An Indian Market Report   Global Industry Analysts, Inc., April 2011, Pages: 402 , which primarily comprises therapeutic drugs, vaccines, animal biologicals, insulin, diagnostics and statins, continues to account for the largest share in total revenues of the biotech industry Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond   Spectra Intelligence, Jan 2006, Pages: 580 - Provides extensive coverage of R&D pipelines of key players in the sector - Shows proprietary market modelling for prospect analysis across 15 main therapy areas. WHAT CAN I LEARN FROM THIS REPORT? - How Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network